文献
J-GLOBAL ID:201802250396837641
整理番号:18A1790879
ペルツズマブ,トラスツズマブおよび化学療法の前治療を受けたHER2陽性局所進行/転移性乳癌患者におけるペルツズマブ再投与の無作為化,非盲検,第III相試験:日本乳癌研究グループ-M05 PRECIOUS試験
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study
著者 (19件):
YAMAMOTO Yutaka
(Kumamoto Univ., Kumamoto)
,
IWATA Hiroji
(Aichi Cancer Center Hospital, Nagoya)
,
UENO Takayuki
(Kyorin Univ. Hospital, Tokyo)
,
TAIRA Naruto
(Okayama Univ. Hospital, Okayama)
,
KASHIWABA Masahiro
(Breastpia Miyazaki Hospital, Miyazak)
,
TAKAHASHI Masato
(National Hospital Organization Hokkaido Cancer Center, Sapporo)
,
TADA Hiroshi
(Tohoku Univ., Sendai)
,
TSUGAWA Koichiro
(St. Marianna Univ. School of Medicine Hospital, Kawasaki)
,
TOYAMA Tatsuya
(Nagoya City Univ. Graduate School of Medical Sci., Nagoya)
,
NIIKURA Naoki
(Tokai Univ. School of Medicine, Isehara)
,
HARA Fumikata
(National Hospital Organization Shikoku Cancer Center, Matsuyama)
,
FUJISAWA Tomomi
(Gunma Prefectural Cancer Center, Ohta)
,
YOSHINAMI Tetsuhiro
(Osaka International Cancer Inst., Osaka)
,
SAJI Shigehira
(Fukushima Medical Univ., Fukushima)
,
TAKANO Toshimi
(Toranomon Hospital, Tokyo)
,
MASUDA Norikazu
(National Hospital Organization Osaka National Hospital, Osaka)
,
MORITA Satoshi
(Kyoto Univ., Kyoto)
,
TOI Masakazu
(Kyoto Univ.)
,
OHNO Shinji
(Cancer Inst. Hospital of JFCR, Tokyo, JPN)
資料名:
Japanese Journal of Clinical Oncology (Web)
(Japanese Journal of Clinical Oncology (Web))
巻:
48
号:
9
ページ:
855-859 (WEB ONLY)
発行年:
2018年09月
JST資料番号:
U1085A
ISSN:
1465-3621
資料種別:
逐次刊行物 (A)
記事区分:
解説
発行国:
イギリス (GBR)
言語:
英語 (EN)